Trial intelligence / Profile preview

ITEM: Telmisartan for RBC Function and Microcirculation

NCT00559286Phase 4Terminated

Sponsor
RWTH Aachen University
Start
Dec 2007
Primary completion
Jan 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of telmisartan in hypertension (HTN), type 2 diabetes mellitus (T2DM), sponsored by RWTH Aachen University. Started Dec 2007; status: terminated.

02

Drugs

telmisartan
03

Conditions

hypertension (HTN)type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT00559286.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00559286.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call